CBC Professor Rebecca Page has been awarded a new contract from Leidos Biomedical Research under their prime NCI contact. Entitled "Crystallization of Novel Alloseteric SHP2", this award began January 2019 and will go through August 2019. This agreement is part of NCI's Experimental Therapeutics Program under the Chemical Biology Consortium (NCI-CBC). This award will aid SHP2 drug development. Congratulations, Rebecca!